Prediction of Glioma enhancement pattern using a MRI radiomics-based model

Contrast-MRI scans carry risks associated with the chemical contrast agents. Accurate prediction of enhancement pattern of gliomas has potential in avoiding contrast agent administration to patients. This study aimed to develop a machine learning radiomics model that can accurately predict enhancement pattern of gliomas based on T2 fluid attenuated inversion recovery images. A total of 385 cases of pathologically-proven glioma were retrospectively collected with preoperative magnetic resonance T2 fluid attenuated inversion recovery images, which were divided into enhancing and non-enhancing groups. Predictive radiomics models based on machine learning with 6 different classifiers were established in the training cohort (n = 201), and tested both in the internal validation cohort (n = 85) and the external validation cohort (n = 99). Receiver-operator characteristic curve was used to assess the predictive performance of these radiomics models. This study demonstrated that the radiomics model comprising of 15 features using the Gaussian process as a classifier had the highest predictive performance in both the training cohort and the internal validation cohort, with the area under the curve being 0.88 and 0.80, respectively. This model showed an area under the curve, sensitivity, specificity, positive predictive value and negative predictive value of 0.81, 0.98, 0.61, 0.82, 0.76 and 0.96, respectively, in the external validation cohort. This study suggests that the T2-FLAIR-based machine learning radiomics model can accurately predict enhancement pattern of glioma.